title: Sustained response of refractory chronic lymphocytic leukemia in progression complicated by acute hemolitic anemia to anti-CD20 monoclonal antibody.
authors.forename: Emilio
authors.initials: E
authors.lastname: Iannitto
authors.forename: Emanuele
authors.initials: E
authors.lastname: Ammatuna
authors.forename: Carla
authors.initials: C
authors.lastname: Marino
authors.forename: Sonia
authors.initials: S
authors.lastname: Cirrincione
authors.forename: Gioacchino
authors.initials: G
authors.lastname: Greco
authors.forename: Gugcielmo
authors.initials: G
authors.lastname: Mariani
mesh_terms: D000208:Acute Disease; D000743:Anemia, Hemolytic / Q000188:drug therapy* / Q000209:etiology; D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents / Q000008:administration & dosage; D005500:Follow-Up Studies; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000150:complications / Q000188:drug therapy*; D008218:Lymphocytosis / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D012074:Remission Induction; D000069283:Rituximab; D016879:Salvage Therapy
chemical_list: D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents; D000069283:Rituximab